ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Safety and feasibility of neoadjuvant combined chemotherapy of breast cancer with paclitaxel carried in a lipid nanoemulsion (LDE) associated with adriamycin and cyclophosphamide (2015)
Mattar, Andre; Ferreira, Luciana B.; Gebrim, Luiz H.; Hegg, Roberto; Maranhão, Raul Cavalcante
Source: Cancer Research. Conference titles: Annual CTRC-AACR San Antonio Breast Cancer Symposium. Unidades: FM, FCF
Subjects: QUIMIOTERAPIA, NEOPLASIAS MAMÁRIAS (QUIMIOTERAPIA), ANTINEOPLÁSICOS, NANOCOMPOSITOS, CO-TERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTAR, Andre et al. Safety and feasibility of neoadjuvant combined chemotherapy of breast cancer with paclitaxel carried in a lipid nanoemulsion (LDE) associated with adriamycin and cyclophosphamide. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS14-P6-02-06. Acesso em: 18 jun. 2024. , 2015
APA
Mattar, A., Ferreira, L. B., Gebrim, L. H., Hegg, R., & Maranhão, R. C. (2015). Safety and feasibility of neoadjuvant combined chemotherapy of breast cancer with paclitaxel carried in a lipid nanoemulsion (LDE) associated with adriamycin and cyclophosphamide. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS14-P6-02-06
NLM
Mattar A, Ferreira LB, Gebrim LH, Hegg R, Maranhão RC. Safety and feasibility of neoadjuvant combined chemotherapy of breast cancer with paclitaxel carried in a lipid nanoemulsion (LDE) associated with adriamycin and cyclophosphamide [Internet]. Cancer Research. 2015 ; 75[citado 2024 jun. 18 ] Available from: https://doi.org/10.1158/1538-7445.SABCS14-P6-02-06
Vancouver
Mattar A, Ferreira LB, Gebrim LH, Hegg R, Maranhão RC. Safety and feasibility of neoadjuvant combined chemotherapy of breast cancer with paclitaxel carried in a lipid nanoemulsion (LDE) associated with adriamycin and cyclophosphamide [Internet]. Cancer Research. 2015 ; 75[citado 2024 jun. 18 ] Available from: https://doi.org/10.1158/1538-7445.SABCS14-P6-02-06
Artigo de periodico
Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer (2012)
Pires, L. A.; Hegg, R.; Freitas, E. R.; Tavares, E. R.; Almeida, C. P.; Baracat, E. C.; Maranhão, Raul Cavalcante
Source: Brazilian Journal of Medical and Biological Research. Unidades: FM, FCF
Subjects: QUIMIOTERAPIA ADJUVANTE, EXPRESSÃO GÊNICA, CARCINOMA, NEOPLASIAS MAMÁRIAS, MASTECTOMIA, METÁSTASE NEOPLÁSICA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIRES, L. A. et al. Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer. Brazilian Journal of Medical and Biological Research, v. 45, n. 6, p. 557-564, 2012Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2012007500068. Acesso em: 18 jun. 2024.
APA
Pires, L. A., Hegg, R., Freitas, E. R., Tavares, E. R., Almeida, C. P., Baracat, E. C., & Maranhão, R. C. (2012). Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer. Brazilian Journal of Medical and Biological Research, 45( 6), 557-564. doi:10.1590/s0100-879x2012007500068
NLM
Pires LA, Hegg R, Freitas ER, Tavares ER, Almeida CP, Baracat EC, Maranhão RC. Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer [Internet]. Brazilian Journal of Medical and Biological Research. 2012 ; 45( 6): 557-564.[citado 2024 jun. 18 ] Available from: https://doi.org/10.1590/s0100-879x2012007500068
Vancouver
Pires LA, Hegg R, Freitas ER, Tavares ER, Almeida CP, Baracat EC, Maranhão RC. Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer [Internet]. Brazilian Journal of Medical and Biological Research. 2012 ; 45( 6): 557-564.[citado 2024 jun. 18 ] Available from: https://doi.org/10.1590/s0100-879x2012007500068
Trabalho de evento-resumo periodico
Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemothrapy (2009)
Graziani, Silvia Regina; Mendes, Sergio; Vitório, Tatiana Solano; Padoveze, Amanda Felippe; Hegg, Roberto; Bydlowski, Sérgio Paulo; Maranhão, Raul Cavalcante
Source: Journal of Clinical Oncology. Conference titles: Annual Scientific Meeting of the American Society of Clinical Oncology. Unidades: FM, FCF
Subjects: NEOPLASIAS MAMÁRIAS, EMULSÕES (FORMAS FARMACÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRAZIANI, Silvia Regina et al. Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemothrapy. Journal of Clinical Oncology. Alexandria: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 18 jun. 2024. , 2009
APA
Graziani, S. R., Mendes, S., Vitório, T. S., Padoveze, A. F., Hegg, R., Bydlowski, S. P., & Maranhão, R. C. (2009). Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemothrapy. Journal of Clinical Oncology. Alexandria: Faculdade de Medicina, Universidade de São Paulo.
NLM
Graziani SR, Mendes S, Vitório TS, Padoveze AF, Hegg R, Bydlowski SP, Maranhão RC. Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemothrapy. Journal of Clinical Oncology. 2009 ; 25( 15):[citado 2024 jun. 18 ]
Vancouver
Graziani SR, Mendes S, Vitório TS, Padoveze AF, Hegg R, Bydlowski SP, Maranhão RC. Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemothrapy. Journal of Clinical Oncology. 2009 ; 25( 15):[citado 2024 jun. 18 ]
Trabalho de evento-resumo periodico
One hour infusion of clodronate disodium for treating oncological pain due to bone metastases of solid tumors among adults (2008)
Graziani, Silvia Regina; Graziani, Silvana Maria; Bossa, Nádia Aparecida; Hegg, Roberto; Maranhão, Raul Cavalcante
Source: Cancer Treatment Reviews. Conference titles: International Meeting on Cancer Induced Bone Disease. Unidades: FM, FCF
Assunto: METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRAZIANI, Silvia Regina et al. One hour infusion of clodronate disodium for treating oncological pain due to bone metastases of solid tumors among adults. Cancer Treatment Reviews. Oxford: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 18 jun. 2024. , 2008
APA
Graziani, S. R., Graziani, S. M., Bossa, N. A., Hegg, R., & Maranhão, R. C. (2008). One hour infusion of clodronate disodium for treating oncological pain due to bone metastases of solid tumors among adults. Cancer Treatment Reviews. Oxford: Faculdade de Medicina, Universidade de São Paulo.
NLM
Graziani SR, Graziani SM, Bossa NA, Hegg R, Maranhão RC. One hour infusion of clodronate disodium for treating oncological pain due to bone metastases of solid tumors among adults. Cancer Treatment Reviews. 2008 ; 34 S83-S84 res. P75.[citado 2024 jun. 18 ]
Vancouver
Graziani SR, Graziani SM, Bossa NA, Hegg R, Maranhão RC. One hour infusion of clodronate disodium for treating oncological pain due to bone metastases of solid tumors among adults. Cancer Treatment Reviews. 2008 ; 34 S83-S84 res. P75.[citado 2024 jun. 18 ]

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em